id,name,comment,phosphosite,uniprot,PMID,pdb_id29956,Pde3b,"Promotes 14-3-3 binding and increased Pde3b activity (<a href='http://pubmed.org/10454575' target='_blank' title='Open in PubMed'>Kitamura et al., 1999</a>; <a href='http://pubmed.org/12453887' target='_blank' title='Open in PubMed'>Onuma et al., 2002</a>). Pde3b catalyses hydrolysis of cAMP, influencing cAMP-dependent processes. For instance, this deactivates hormone-sensitive lipase and lipolysis in adipocytes.",S272,B2RWU9,"10454575, 12453887",21925,ULK1,"mTORC1 phosphorylates Ulk1 at Ser757, which affects the interaction between Ulk1 and AMPK (<a href='http://pubmed.org/21258367' target='_blank' title='Open in PubMed'>Kim et al., 2011</a>; <a href='http://pubmed.org/21383122' target='_blank' title='Open in PubMed'>Shang et al., 2011</a>). Although there is conflicting evidence about the direction and effect of this interaction, there is a consensus that this prevents autophagy when nutrients are not limiting.",S763,O70405,"21258367, 21383122",2hak32877,PKA,"Protein kinase A (PKA) is stimulated when 1) cAMP binds the PKA regulatory subunits, dissociating them from the catalytic subunits (PKACA), and 2) PDK1 phosphorylates PKACA at T198 (<a href='http://pubmed.org/9488457' target='_blank' title='Open in PubMed'>Cauthron et al., 1998</a>; <a href='http://pubmed.org/9707564' target='_blank' title='Open in PubMed'>Cheng et al., 1998</a>; <a href='http://pubmed.org/12372837' target='_blank' title='Open in PubMed'>Moore et al., 2002</a>). This site is found within the activation loop, generating conformational changes that lead to active PKA.",T198,P05132,"9488457, 9707564, 12372837",4dfy7591,Brf1,"Promotes 14-3-3 binding. This impairs its role in degrading mRNA molecules that contain AU-rich elements. 14-3-3 binding also protects Brf1 from degradation, perhaps to enable rapid mRNA decay once the insulin stimulus is removed (<a href='http://pubmed.org/15538381' target='_blank' title='Open in PubMed'>Schmidlin et al., 2004</a>; <a href='http://pubmed.org/17030608' target='_blank' title='Open in PubMed'>Benjamin et al., 2006</a>).",S92,P23950,"15538381, 17030608",1rgo6241,HSF1,"In response to growth factors, MAPK phosphorylates HSF1 at S307, which primes GSK3 to phosphorylate at S303 (<a href='http://pubmed.org/8940068' target='_blank' title='Open in PubMed'>Chu et al., 1996</a>). This promotes 14-3-3 binding, sequestering HSF1 in the cytoplasm and thus repressing its transcriptional activity (<a href='http://pubmed.org/12917326' target='_blank' title='Open in PubMed'>Wang et al., 2003</a>). This represses the heat shock response during processes stimulated by growth-factors, such as cellular proliferation.",S303,P38532,"8940068, 12917326",2ldu6242,HSF1,"In response to growth factors, MAPK phosphorylates HSF1 at S307, which primes GSK3 to phosphorylate at S303 (<a href='http://pubmed.org/8940068' target='_blank' title='Open in PubMed'>Chu et al., 1996</a>). This promotes 14-3-3 binding, sequestering HSF1 in the cytoplasm and thus repressing its transcriptional activity (<a href='http://pubmed.org/12917326' target='_blank' title='Open in PubMed'>Wang et al., 2003</a>). This represses the heat shock response during processes stimulated by growth-factors, such as cellular proliferation.",S307,P38532,"8940068, 12917326",2ldu6246,HSF1,"In response to stresses such as heat shock, mTORC1 phosphorylates HSF1 at S326, leading to the upregulation of heat-shock proteins (e.g. Hsp70) to combat cellular stress (<a href='http://pubmed.org/22768106' target='_blank' title='Open in PubMed'>Chou et al., 2012</a>).",S326,P38532,22768106,2ldu1143,Rps6,"p70S6K phosphorylates RPS6 (S6), a component in the 40S ribosomal subunit, at several sites, including S236 and S240 (<a href='http://pubmed.org/1939282' target='_blank' title='Open in PubMed'>Ferrari et al., 1991</a>). Some studies support this results in the selective translation of a subset of mRNAs, 5'TOP mRNAs, (e.g., <a href='http://pubmed.org/9218810' target='_blank' title='Open in PubMed'>Jefferies et al., 1997</a>), this remains controversial (e.g., <a href='http://pubmed.org/11972328' target='_blank' title='Open in PubMed'>Barth-Baus et al., 2002</a>; <a href='http://pubmed.org/16166381' target='_blank' title='Open in PubMed'>Ruvinsky et al., 2005</a>). There is also evidence that S236 phosphorylation promotes binding to the 7-methylguanosine cap-binding complex, to initiate translation (<a href='http://pubmed.org/17360704' target='_blank' title='Open in PubMed'>Roux et al., 2007</a>), but studies have also shown that phosphorylation reduces protein synthesis, slows cell division, and increases cell size (e.g., <a href='http://pubmed.org/16166381' target='_blank' title='Open in PubMed'>Ruvinsky et al., 2005</a>). Thus, the physiological outcome of S6 phosphorylation remains unclear.",S236,P62754,1939282,3j161144,Rps6,"p70S6K phosphorylates RPS6 (S6), a component in the 40S ribosomal subunit, at several sites, including S236 and S240 (<a href='http://pubmed.org/1939282' target='_blank' title='Open in PubMed'>Ferrari et al., 1991</a>). Some studies support this results in the selective translation of a subset of mRNAs, 5'TOP mRNAs, (e.g., <a href='http://pubmed.org/9218810' target='_blank' title='Open in PubMed'>Jefferies et al., 1997</a>), this remains controversial (e.g., <a href='http://pubmed.org/11972328' target='_blank' title='Open in PubMed'>Barth-Baus et al., 2002</a>; <a href='http://pubmed.org/16166381' target='_blank' title='Open in PubMed'>Ruvinsky et al., 2005</a>). There is also evidence that S236 phosphorylation promotes binding to the 7-methylguanosine cap-binding complex, to initiate translation (<a href='http://pubmed.org/17360704' target='_blank' title='Open in PubMed'>Roux et al., 2007</a>), but studies have also shown that phosphorylation reduces protein synthesis, slows cell division, and increases cell size (e.g., <a href='http://pubmed.org/16166381' target='_blank' title='Open in PubMed'>Ruvinsky et al., 2005</a>). Thus, the physiological outcome of S6 phosphorylation remains unclear.",S240,P62754,1939282,3j1631143,Erk2,"MEK1/2 phosphorylates ERK1/2 within the 'activation lip', on T203/Y205 in ERK1 and T183/Y185 in ERK2 (<a href='http://pubmed.org/1849075' target='_blank' title='Open in PubMed'>Payne et al., 1991</a>; <a href='http://pubmed.org/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/8626767' target='_blank' title='Open in PubMed'>Butch & Guan, 1996</a>; <a href='http://pubmed.org/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>). Phosphorylation is favoured first on the tyrosine residue before the threonine residue (<a href='http://pubmed.org/9228083' target='_blank' title='Open in PubMed'>Ferrell & Bhatt, 1997</a>; <a href='http://pubmed.org/1628739' target='_blank' title='Open in PubMed'>Haystead et al., 1992</a>). This leads to activation of ERK1/2, enabling regulation of a diverse range of cellular responses to external stimuli (<a href='http://pubmed.org/22569528' target='_blank' title='Open in PubMed'>Roskoski, 2012</a>). Furthermore, ERK1/2 has the ability to autophosphorylate itself at these sites (<a href='http://pubmed.org/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>), but a 'gatekeeper' site prevents this to maintain low basal ERK1/2 activity (<a href='http://pubmed.org/17114285' target='_blank' title='Open in PubMed'>Emrick et al., 2006</a>).",T183,P63085,"1849075, 8444886, 8626767, 7504457, 9228083, 1628739, 22569528, 17114285",3r6337331,Erk2,"MEK1/2 phosphorylates ERK1/2 within the 'activation lip', on T203/Y205 in ERK1 and T183/Y185 in ERK2 (<a href='http://pubmed.org/1849075' target='_blank' title='Open in PubMed'>Payne et al., 1991</a>; <a href='http://pubmed.org/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/8626767' target='_blank' title='Open in PubMed'>Butch & Guan, 1996</a>; <a href='http://pubmed.org/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>). Phosphorylation is favoured first on the tyrosine residue before the threonine residue (<a href='http://pubmed.org/9228083' target='_blank' title='Open in PubMed'>Ferrell & Bhatt, 1997</a>; <a href='http://pubmed.org/1628739' target='_blank' title='Open in PubMed'>Haystead et al., 1992</a>). This leads to activation of ERK1/2, enabling regulation of a diverse range of cellular responses to external stimuli (<a href='http://pubmed.org/22569528' target='_blank' title='Open in PubMed'>Roskoski, 2012</a>). Furthermore, ERK1/2 has the ability to autophosphorylate itself at these sites (<a href='http://pubmed.org/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>), but a 'gatekeeper' site prevents this to maintain low basal ERK1/2 activity (<a href='http://pubmed.org/17114285' target='_blank' title='Open in PubMed'>Emrick et al., 2006</a>).",Y185,P63085,"1849075, 8444886, 8626767, 7504457, 9228083, 1628739, 22569528, 17114285",3r637476,Pfkfb2,"There is strong evidence to suggest that PFKFB2 (cardiac PFK-2) is phosphorylated at S469 and S486 by Akt, leading to 14-3-3 binding and increased activity (<a href='http://pubmed.org/9211863' target='_blank' title='Open in PubMed'>Deprez et al., 1997</a>; <a href='http://pubmed.org/12853467' target='_blank' title='Open in PubMed'>Pozuelo et al., 2003</a>; <a href='http://pubmed.org/20958264' target='_blank' title='Open in PubMed'>Moon et al., 2011</a>). This elevates levels of its product, fructose-2,6-bisphosphate, which stimulates glycolysis.",S469,P70265,"9211863, 12853467, 20958264",1fbt7477,Pfkfb2,"There is strong evidence to suggest that PFKFB2 (cardiac PFK-2) is phosphorylated at S469 and S486 by Akt, leading to 14-3-3 binding and increased activity (<a href='http://pubmed.org/9211863' target='_blank' title='Open in PubMed'>Deprez et al., 1997</a>; <a href='http://pubmed.org/12853467' target='_blank' title='Open in PubMed'>Pozuelo et al., 2003</a>; <a href='http://pubmed.org/20958264' target='_blank' title='Open in PubMed'>Moon et al., 2011</a>). This elevates levels of its product, fructose-2,6-bisphosphate, which stimulates glycolysis.",S486,P70265,"9211863, 12853467, 20958264",1fbt23370,eNOS,"Activates eNOS, reducing its requirement for Ca2+ and increasing production of nitric oxide. This signalling molecule plays a role in numerous processes including vasodilation (<a href='http://pubmed.org/10376603' target='_blank' title='Open in PubMed'>Dimmeler et al., 1999</a>).",S1176,P70313,10376603,3nos24474,GSK3a,"GSK3a/b are unique kinase in that they requires its substrate to be phosphorylated at a residue +4 of the GSK3 target site. The GSK3 domain that binds this 'priming site' is occupied by the GSK3 N-terminus when S9/21 (GSK3b/a) is phosphorylated by Akt (<a href='http://pubmed.org/11430833' target='_blank' title='Open in PubMed'>Frame et al., 2001</a>). This leads to disrupted GSK3 activity (<a href='http://pubmed.org/8524413' target='_blank' title='Open in PubMed'>Cross et al., 1995</a>). This not only derepresses glycogen synthesis (<a href='http://pubmed.org/8816781' target='_blank' title='Open in PubMed'>Eldar-Finkelman et al., 1996</a>), for which GSK3 is named, but influences a wide range of cellular processes (reviewed in <a href='http://pubmed.org/11579232' target='_blank' title='Open in PubMed'>Woodgett, 2001</a>).",S21,Q2NL51,"11430833, 8524413, 8816781, 11579232",2ow31212,p90RSK,"MAPK/ERK phosphorylates p90(RSK) on several residues, including S363 (<a href='http://pubmed.org/9430688' target='_blank' title='Open in PubMed'>Dalby et al., 1998</a>). This residue is found within the N-terminal kinase domain, contributing to the activation of p90(RSK).",S363,Q3TIM6,9430688,3943,TAK1,"Protein kinase A phosphorylates TAK1 on S439. This allows cAMP/PKA-dependent signals, such as prostaglandin E2, to enhance downstream signalling pathways, including MAPK and NF-Kb, subsequently promoting osteoclast differentiation (<a href='http://pubmed.org/15647289' target='_blank' title='Open in PubMed'>Kobayashi et al., 2005</a>). This is in concordance with the role that TAK1 plays in directing differentiation away from adipogenesis (<a href='http://pubmed.org/12598905' target='_blank' title='Open in PubMed'>Suzawa et al., 2003</a>).",S439,Q3TXG1,15647289,23681,Irs1,"Following insulin stimulation, S522 of IRS-1 is phosphorylated by S6K (<a href='http://pubmed.org/16914728' target='_blank' title='Open in PubMed'>Shah & Hunter, 2006</a>), which reduces tyrosine phosphorylation of IRS-1 (<a href='http://pubmed.org/17579213' target='_blank' title='Open in PubMed'>Giraud et al., 2007</a>). This provides a feedback loop to regulate insulin signalling.",S526,Q543V3,"16914728, 17579213",37636,Irs1,"Upon insulin stimulation, IRS-1 is phosphorylated by the insulin receptor at numerous tyrosine residues. These serve as docking sites for SH2-binding proteins. From the phosphosites shown, Y680 (and Y460 to some extent) bind the p85 subunit of PI3K (<a href='http://pubmed.org/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>), mediating the PI3K/Akt pathway; Y891 binds GRB2 to activate Ras/MAPK (<a href='http://pubmed.org/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/8196603' target='_blank' title='Open in PubMed'>Myers et al., 1994</a>); Y1173 binds SHPTP2 to also activate Ras/MAPK (<a href='http://pubmed.org/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/7935386' target='_blank' title='Open in PubMed'>Noguchi et al., 1994</a>). Thus, IRS-1 acts as a divergence point, stimulating multiple signalling pathways in response to insulin.",Y891,Q543V3,"7504175, 8196603, 7935386",37639,Irs1,"Upon insulin stimulation, IRS-1 is phosphorylated by the insulin receptor at numerous tyrosine residues. These serve as docking sites for SH2-binding proteins. From the phosphosites shown, Y680 (and Y460 to some extent) bind the p85 subunit of PI3K (<a href='http://pubmed.org/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>), mediating the PI3K/Akt pathway; Y891 binds GRB2 to activate Ras/MAPK (<a href='http://pubmed.org/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/8196603' target='_blank' title='Open in PubMed'>Myers et al., 1994</a>); Y1173 binds SHPTP2 to also activate Ras/MAPK (<a href='http://pubmed.org/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/7935386' target='_blank' title='Open in PubMed'>Noguchi et al., 1994</a>). Thus, IRS-1 acts as a divergence point, stimulating multiple signalling pathways in response to insulin.",Y460,Q543V3,"7504175, 8196603, 7935386",37640,Irs1,"Upon insulin stimulation, IRS-1 is phosphorylated by the insulin receptor at numerous tyrosine residues. These serve as docking sites for SH2-binding proteins. From the phosphosites shown, Y608 (and Y460 to some extent) bind the p85 subunit of PI3K (<a href='http://pubmed.org/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>), mediating the PI3K/Akt pathway; Y891 binds GRB2 to activate Ras/MAPK (<a href='http://pubmed.org/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/8196603' target='_blank' title='Open in PubMed'>Myers et al., 1994</a>); Y1173 binds SHPTP2 to also activate Ras/MAPK (<a href='http://pubmed.org/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/7935386' target='_blank' title='Open in PubMed'>Noguchi et al., 1994</a>). Thus, IRS-1 acts as a divergence point, stimulating multiple signalling pathways in response to insulin.",Y608,Q543V3,"7504175, 8196603, 7935386",37643,Irs1,"Upon insulin stimulation, IRS-1 is phosphorylated by the insulin receptor at numerous tyrosine residues. These serve as docking sites for SH2-binding proteins. From the phosphosites shown, Y608 (and Y460 to some extent) bind the p85 subunit of PI3K (<a href='http://pubmed.org/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>), mediating the PI3K/Akt pathway; Y891 binds GRB2 to activate Ras/MAPK (<a href='http://pubmed.org/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/8196603' target='_blank' title='Open in PubMed'>Myers et al., 1994</a>); Y1173 binds SHPTP2 to also activate Ras/MAPK (<a href='http://pubmed.org/7504175' target='_blank' title='Open in PubMed'>Sun et al., 1993</a>; <a href='http://pubmed.org/7935386' target='_blank' title='Open in PubMed'>Noguchi et al., 1994</a>). Thus, IRS-1 acts as a divergence point, stimulating multiple signalling pathways in response to insulin.",Y1171,Q543V3,"7504175, 8196603, 7935386",37334,InsR,"Upon binding insulin, the insulin receptor phosphorylates itself on mouse Y1175, Y1179, Y1180 (human Y1185, Y1189, and Y1190), both in vitro and in vivo (<a href='http://pubmed.org/2449432' target='_blank' title='Open in PubMed'>White et al., 1988</a>; <a href='http://pubmed.org/3166375' target='_blank' title='Open in PubMed'>Tavaré & Denton, 1988</a>; <a href='http://pubmed.org/2158467' target='_blank' title='Open in PubMed'>Kruszynska et al., 1990</a>), leading to its activation (<a href='http://pubmed.org/1658004' target='_blank' title='Open in PubMed'>Murakami & Rosen, 1991</a>) and stimulation of insulin-responsive pathways, such as glucose uptake in fat and muscle.",Y1175,Q60751,"2449432, 3166375, 2158467, 1658004",1m7n37335,InsR,"Upon binding insulin, the insulin receptor phosphorylates itself on mouse Y1175, Y1179, Y1180 (human Y1185, Y1189, and Y1190), both in vitro and in vivo (<a href='http://pubmed.org/2449432' target='_blank' title='Open in PubMed'>White et al., 1988</a>; <a href='http://pubmed.org/3166375' target='_blank' title='Open in PubMed'>Tavaré & Denton, 1988</a>; <a href='http://pubmed.org/2158467' target='_blank' title='Open in PubMed'>Kruszynska et al., 1990</a>), leading to its activation (<a href='http://pubmed.org/1658004' target='_blank' title='Open in PubMed'>Murakami & Rosen, 1991</a>) and stimulation of insulin-responsive pathways, such as glucose uptake in fat and muscle.",Y1179,Q60751,"2449432, 3166375, 2158467, 1658004",1m7n37336,InsR,"Upon binding insulin, the insulin receptor phosphorylates itself on mouse Y1175, Y1179, Y1180 (human Y1185, Y1189, and Y1190), both in vitro and in vivo (<a href='http://pubmed.org/2449432' target='_blank' title='Open in PubMed'>White et al., 1988</a>; <a href='http://pubmed.org/3166375' target='_blank' title='Open in PubMed'>Tavaré & Denton, 1988</a>; <a href='http://pubmed.org/2158467' target='_blank' title='Open in PubMed'>Kruszynska et al., 1990</a>), leading to its activation (<a href='http://pubmed.org/1658004' target='_blank' title='Open in PubMed'>Murakami & Rosen, 1991</a>) and stimulation of insulin-responsive pathways, such as glucose uptake in fat and muscle.",Y1180,Q60751,"2449432, 3166375, 2158467, 1658004",1m7n4944,Grb10,"Enhances stability of Grb10. This reduces signalling through insulin receptor or by influencing mTORC1 instead (<a href='http://pubmed.org/21659604' target='_blank' title='Open in PubMed'>Hsu et al., 2011</a>; <a href='http://pubmed.org/21659605' target='_blank' title='Open in PubMed'>Yu et al., 2011</a>; <a href='http://pubmed.org/24746805' target='_blank' title='Open in PubMed'></a>). Nevertheless, this phosphorylation site leads to feedback regulation of insulin signalling.",S503,Q60760,"21659604, 21659605, 24746805",3m7f3081,Akt,"Found in C-terminal hydrophobic motif. Phosphorylation at this site stimulates Akt activity (<a href='http://pubmed.org/9445477' target='_blank' title='Open in PubMed'>Stephens et al., 1998</a>).",S474,Q60823,9445477,1p6s31272,Akt,"Found in activation loop of the kinase domain. Primes Akt for second phosphorylation (at S474) for complete activation (<a href='http://pubmed.org/15718470' target='_blank' title='Open in PubMed'>Sarbassov et al., 2005</a>).",T309,Q60823,15718470,1p6s13766,Eif4ebp1,"Phosphorylation at several sites by mTORC1 (T36, T45, and T69, then S64) causes 4E-BP1 to disocciate from eIF4E. This enables eIF4E to bind the 5' cap of mRNAs, resulting in the initiation of translation (<a href='http://pubmed.org/10779345' target='_blank' title='Open in PubMed'>Mothe-Satney et al., 2000</a>).",S64,Q60876,10779345,3m9333654,Eif4ebp1,"Phosphorylation at several sites by mTORC1 (T36, T45, and T69, then S64) causes 4E-BP1 to disocciate from eIF4E. This enables eIF4E to bind the 5' cap of mRNAs, resulting in the initiation of translation (<a href='http://pubmed.org/10779345' target='_blank' title='Open in PubMed'>Mothe-Satney et al., 2000</a>).",T36,Q60876,10779345,3m9333657,Eif4ebp1,"Phosphorylation at several sites by mTORC1 (T36, T45, and T69, then S64) causes 4E-BP1 to disocciate from eIF4E. This enables eIF4E to bind the 5' cap of mRNAs, resulting in the initiation of translation (<a href='http://pubmed.org/10779345' target='_blank' title='Open in PubMed'>Mothe-Satney et al., 2000</a>).",T45,Q60876,10779345,3m9311430,TSC2,"Akt phosphorylates TSC2 on several sites, including S939, S981 and T1423/62 (<a href='http://pubmed.org/12150915' target='_blank' title='Open in PubMed'>Manning et al., 2002</a>; <a href='http://pubmed.org/12172553' target='_blank' title='Open in PubMed'>Inoki et al., 2002</a>; <a href='http://pubmed.org/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>). Whilst there is conflicting evidence about whether its interaction with binding partner TSC1 is affected (<a href='http://pubmed.org/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>; <a href='http://pubmed.org/12167664' target='_blank' title='Open in PubMed'>Dan et al., 2002</a>), studies suggest phosphorylation promotes 14-3-3 binding (<a href='http://pubmed.org/12438239' target='_blank' title='Open in PubMed'>Liu et al., 2002</a>; <a href='http://pubmed.org/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>), cytoplasmic localisation (<a href='http://pubmed.org/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>), and ultimately its degradation (<a href='http://pubmed.org/12172553' target='_blank' title='Open in PubMed'>Inoki et al., 2002</a>; <a href='http://pubmed.org/12167664' target='_blank' title='Open in PubMed'>Dan et al., 2002</a>). This derepresses mTORC1 activity, promoting protein and lipid synthesis in response to mitogenic and nutrient stimuli.",S981,Q61037,,3brw11441,TSC2,"Akt phosphorylates TSC2 on several sites, including S939, S981 and T1423/62 (<a href='http://pubmed.org/12150915' target='_blank' title='Open in PubMed'>Manning et al., 2002</a>; <a href='http://pubmed.org/12172553' target='_blank' title='Open in PubMed'>Inoki et al., 2002</a>; <a href='http://pubmed.org/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>). Whilst there is conflicting evidence about whether its interaction with binding partner TSC1 is affected (<a href='http://pubmed.org/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>; <a href='http://pubmed.org/12167664' target='_blank' title='Open in PubMed'>Dan et al., 2002</a>), studies suggest phosphorylation promotes 14-3-3 binding (<a href='http://pubmed.org/12438239' target='_blank' title='Open in PubMed'>Liu et al., 2002</a>; <a href='http://pubmed.org/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>), cytoplasmic localisation (<a href='http://pubmed.org/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>), and ultimately its degradation (<a href='http://pubmed.org/12172553' target='_blank' title='Open in PubMed'>Inoki et al., 2002</a>; <a href='http://pubmed.org/12167664' target='_blank' title='Open in PubMed'>Dan et al., 2002</a>). This derepresses mTORC1 activity, promoting protein and lipid synthesis in response to mitogenic and nutrient stimuli.",S939,Q61037,,3brw33125,TSC2,"Akt phosphorylates TSC2 on several sites, including S939, S981 and T1443/1465 (<a href='http://pubmed.org/12150915' target='_blank' title='Open in PubMed'>Manning et al., 2002</a>; <a href='http://pubmed.org/12172553' target='_blank' title='Open in PubMed'>Inoki et al., 2002</a>; <a href='http://pubmed.org/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>). Whilst there is conflicting evidence about whether its interaction with binding partner TSC1 is affected (<a href='http://pubmed.org/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>; <a href='http://pubmed.org/12167664' target='_blank' title='Open in PubMed'>Dan et al., 2002</a>), studies suggest phosphorylation promotes 14-3-3 binding (<a href='http://pubmed.org/12438239' target='_blank' title='Open in PubMed'>Liu et al., 2002</a>; <a href='http://pubmed.org/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>), cytoplasmic localisation (<a href='http://pubmed.org/16636147' target='_blank' title='Open in PubMed'>Cai et al., 2006</a>), and ultimately its degradation (<a href='http://pubmed.org/12172553' target='_blank' title='Open in PubMed'>Inoki et al., 2002</a>; <a href='http://pubmed.org/12167664' target='_blank' title='Open in PubMed'>Dan et al., 2002</a>). This derepresses mTORC1 activity, promoting protein and lipid synthesis in response to mitogenic and nutrient stimuli.",T1466,Q61037,,3brw1816,Mekk3,"SGK1 phosphorylates MEKK3 (MAP3K3) on S337 (and S166), reducing its kinase activity (<a href='http://pubmed.org/12761204' target='_blank' title='Open in PubMed'>Chun et al., 2003</a>). Since MEKK3 regulates the stress-activated (SAPK) and mitogen-activated (MAPK) protein kinase pathways, this provides a way for SGK1 to turn off these pathways, enabling cross-talk between kinase signalling pathways.",S337,Q61084,12761204,2jrh17539,NHE1,"NHE1 is phosphorylated at this site by p90(RSK). Promotes 14-3-3 binding (<a href='http://pubmed.org/11279064' target='_blank' title='Open in PubMed'>Lehoux et al., 2001</a>), leading to increased Na+/H+ exchange and cell alkalinisation (<a href='http://pubmed.org/10400637' target='_blank' title='Open in PubMed'>Takahashi et al., 1999</a>). Whilst this has been shown to exacerbate myocardial ischemia and reperfusion injury (<a href='http://pubmed.org/16717153' target='_blank' title='Open in PubMed'>Maekawa et al., 2006</a>), it may also be necessary for cell cycle progression (<a href='http://pubmed.org/19622752' target='_blank' title='Open in PubMed'>Meima et al., 2009</a>).",S707,Q61165,10400637,2e3026140,BAD,"In a PKC-dependent manner, p90RSK phosphorylates this site. This promotes14-3-3 binding, blocking BAD from heterodimerising with Bcl-XL, thus promoting cell survival and inhibiting apoptosis (<a href='http://pubmed.org/8929531' target='_blank' title='Open in PubMed'>Zha et al., 1996</a>; <a href='http://pubmed.org/10574959' target='_blank' title='Open in PubMed'>Tan et al., 1999</a>).",S112,Q61337,"8929531, 10574959",2bzw26145,BAD,"Promotes 14-3-3 binding preventing BAD from heterodimerising with Bcl-XL, promoting cell survival and inhibiting apoptosis (<a href='http://pubmed.org/8929531' target='_blank' title='Open in PubMed'>Zha et al., 1996</a>; <a href='http://pubmed.org/9346240' target='_blank' title='Open in PubMed'>Datta et al., 1997</a>).",S136,Q61337,"8929531, 9346240",2bzw12994,SOS1,"MAP kinase (MAPK) phosphorylates SOS1 on several sites, including S1178, S1183, S1197, which causes disassociation of the Sos1-Grb2 complex (<a href='http://pubmed.org/8816480' target='_blank' title='Open in PubMed'>Corbalan-Garcia et al., 1996</a>). Since Sos1-Grb2 connects receptor tyrosine kinases to Ras and MAPK downstream, this serves as a feedback mechanism for Ras/MAPK signalling (e.g., <a href='http://pubmed.org/7829473' target='_blank' title='Open in PubMed'>Cherniack et al., 1995</a>).",S1179,Q62245,8816480,1pms12995,SOS1,"MAP kinase (MAPK) phosphorylates SOS1 on several sites, including S1178, S1183, S1197, which causes disassociation of the Sos1-Grb2 complex (<a href='http://pubmed.org/8816480' target='_blank' title='Open in PubMed'>Corbalan-Garcia et al., 1996</a>). Since Sos1-Grb2 connects receptor tyrosine kinases to Ras and MAPK downstream, this serves as a feedback mechanism for Ras/MAPK signalling (e.g., <a href='http://pubmed.org/7829473' target='_blank' title='Open in PubMed'>Cherniack et al., 1995</a>).",S1183,Q62245,8816480,1pms13015,SOS1,"MAP kinase (MAPK) phosphorylates SOS1 on several sites, including S1178, S1183, S1197, which causes disassociation of the Sos1-Grb2 complex (<a href='http://pubmed.org/8816480' target='_blank' title='Open in PubMed'>Corbalan-Garcia et al., 1996</a>). Since Sos1-Grb2 connects receptor tyrosine kinases to Ras and MAPK downstream, this serves as a feedback mechanism for Ras/MAPK signalling (e.g., <a href='http://pubmed.org/7829473' target='_blank' title='Open in PubMed'>Cherniack et al., 1995</a>).",S1196,Q62245,8816480,1pms4497,Ndrg1,"SGK kinases phosphorylate T328, S330, T346, T356, and T366 of NDRG1 (the latter three found within a triple 10-residue repeat sequence) (<a href='http://pubmed.org/15461589' target='_blank' title='Open in PubMed'>Murray et al., 2004</a>; <a href='http://pubmed.org/20416281' target='_blank' title='Open in PubMed'>Murakami et al., 2010</a>). This primes NDRG1 for phosphorylation by GSK3 (<a href='http://pubmed.org/15461589' target='_blank' title='Open in PubMed'>Murray et al., 2004</a>). Phosphorylation of NDRG1 influences its role in stress responses, such as the suppression of NF-Kb signalling and CXC chemokine production (<a href='http://pubmed.org/20416281' target='_blank' title='Open in PubMed'>Murakami et al., 2010</a>).",S330,Q62433,"15461589, 20416281",2xmr31569,Ndrg1,"SGK kinases phosphorylate T328, S330, T346, T356, and T366 of NDRG1 (the latter three found within a triple 10-residue repeat sequence) (<a href='http://pubmed.org/15461589' target='_blank' title='Open in PubMed'>Murray et al., 2004</a>; <a href='http://pubmed.org/20416281' target='_blank' title='Open in PubMed'>Murakami et al., 2010</a>). This primes NDRG1 for phosphorylation by GSK3 (<a href='http://pubmed.org/15461589' target='_blank' title='Open in PubMed'>Murray et al., 2004</a>). Phosphorylation of NDRG1 influences its role in stress responses, such as the suppression of NF-Kb signalling and CXC chemokine production (<a href='http://pubmed.org/20416281' target='_blank' title='Open in PubMed'>Murakami et al., 2010</a>).",T366,Q62433,"15461589, 20416281",2xmr33117,Erk1,"MEK1/2 phosphorylates ERK1/2 within the 'activation lip', on T203/Y205 in ERK1 and T183/Y185 in ERK2 (<a href='http://pubmed.org/1849075' target='_blank' title='Open in PubMed'>Payne et al., 1991</a>; <a href='http://pubmed.org/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/8626767' target='_blank' title='Open in PubMed'>Butch & Guan, 1996</a>; <a href='http://pubmed.org/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>). Phosphorylation is favoured first on the tyrosine residue before the threonine residue (<a href='http://pubmed.org/9228083' target='_blank' title='Open in PubMed'>Ferrell & Bhatt, 1997</a>; <a href='http://pubmed.org/1628739' target='_blank' title='Open in PubMed'>Haystead et al., 1992</a>). This leads to activation of ERK1/2, enabling regulation of a diverse range of cellular responses to external stimuli (<a href='http://pubmed.org/22569528' target='_blank' title='Open in PubMed'>Roskoski, 2012</a>). Furthermore, ERK1/2 has the ability to autophosphorylate itself at these sites (<a href='http://pubmed.org/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>), but a 'gatekeeper' site prevents this to maintain low basal ERK1/2 activity (<a href='http://pubmed.org/17114285' target='_blank' title='Open in PubMed'>Emrick et al., 2006</a>).",T203,Q63844,"1849075, 8444886, 8626767, 7504457, 9228083, 1628739, 22569528, 17114285",4qtb37449,Erk1,"MEK1/2 phosphorylates ERK1/2 within the 'activation lip', on T203/Y205 in ERK1 and T183/Y185 in ERK2 (<a href='http://pubmed.org/1849075' target='_blank' title='Open in PubMed'>Payne et al., 1991</a>; <a href='http://pubmed.org/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/8626767' target='_blank' title='Open in PubMed'>Butch & Guan, 1996</a>; <a href='http://pubmed.org/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>). Phosphorylation is favoured first on the tyrosine residue before the threonine residue (<a href='http://pubmed.org/9228083' target='_blank' title='Open in PubMed'>Ferrell & Bhatt, 1997</a>; <a href='http://pubmed.org/1628739' target='_blank' title='Open in PubMed'>Haystead et al., 1992</a>). This leads to activation of ERK1/2, enabling regulation of a diverse range of cellular responses to external stimuli (<a href='http://pubmed.org/22569528' target='_blank' title='Open in PubMed'>Roskoski, 2012</a>). Furthermore, ERK1/2 has the ability to autophosphorylate itself at these sites (<a href='http://pubmed.org/8444886' target='_blank' title='Open in PubMed'>Robbins et al., 1993</a>; <a href='http://pubmed.org/7504457' target='_blank' title='Open in PubMed'>Her et al., 1993</a>), but a 'gatekeeper' site prevents this to maintain low basal ERK1/2 activity (<a href='http://pubmed.org/17114285' target='_blank' title='Open in PubMed'>Emrick et al., 2006</a>).",Y204,Q63844,"1849075, 8444886, 8626767, 7504457, 9228083, 1628739, 22569528, 17114285",4qtb8828,Eif4b,"p70S6K phosphorylates Ei4b at this site, which promotes association with eIF3 scaffold in the translation preinitiation complex. Here, eIF4A enhances the helicase activity of eIF4A, melting inhibitory secondary structures in the 5'UTR of mRNAs. This enables the 40S ribosomal subunit to bind and initiate translation (<a href='http://pubmed.org/15071500' target='_blank' title='Open in PubMed'>Raught et al., 2004</a>; <a href='http://pubmed.org/16286006' target='_blank' title='Open in PubMed'>Holz et al., 2005</a>).",S422,Q8BGD9,"15071500, 16286006",2j7632613,Sin1,"Akt phosphorylates SIN1, a component of the mTORC2 complex. This activates mTORC2 - amongst its substrates is Akt, thus potentiating a feed-forward signalling loop (<a href='http://pubmed.org/23684622' target='_blank' title='Open in PubMed'>Humphrey et al., 2013</a>).",T86,Q8BKH7,23684622,3voq19782,p70S6K,"mTORC1 phosphorylates S6K-p70 at T412 (<a href='http://pubmed.org/7489717' target='_blank' title='Open in PubMed'>Pearson et al., 1995</a>; <a href='http://pubmed.org/7545671' target='_blank' title='Open in PubMed'>Han et al., 1995</a>), found within a hydrophobic motif downstream of the catalytic domain. This its phosphorylation of 40S ribosomal protein S6, to activate protein synthesis.",S452,Q8BSK8,"7489717, 7545671, 9632736",4l4510125,AS160,"Promotes 14-3-3 binding (although T649 is primary binding site). Disrupts GTPase-activating (GAP) function of AS160 and promotes translocation of GLUT4 glucose transporter to the plasma membrane, increasing glucose uptake (<a href='http://pubmed.org/12637568' target='_blank' title='Open in PubMed'>Sano et al., 2003</a>; <a href='http://pubmed.org/16880201' target='_blank' title='Open in PubMed'>Ramm et al., 2006</a>; <a href='http://pubmed.org/17617058' target='_blank' title='Open in PubMed'>Geraghty et al., 2007</a>).",S324,Q8BYJ6,"12637568, 17617058",3qyb10128,AS160,"Promotes 14-3-3 binding (although T649 is primary binding site). Disrupts GTPase-activating (GAP) function of AS160 and promotes translocation of GLUT4 glucose transporter to the plasma membrane, increasing glucose uptake (<a href='http://pubmed.org/12637568' target='_blank' title='Open in PubMed'>Sano et al., 2003</a>; <a href='http://pubmed.org/16880201' target='_blank' title='Open in PubMed'>Ramm et al., 2006</a>; <a href='http://pubmed.org/17617058' target='_blank' title='Open in PubMed'>Geraghty et al., 2007</a>).",S348,Q8BYJ6,"12637568, 17617058",3qyb10126,AS160,"Promotes 14-3-3 binding (although T649 is primary binding site). Disrupts GTPase-activating (GAP) function of AS160 and promotes translocation of GLUT4 glucose transporter to the plasma membrane, increasing glucose uptake (<a href='http://pubmed.org/12637568' target='_blank' title='Open in PubMed'>Sano et al., 2003</a>; <a href='http://pubmed.org/16880201' target='_blank' title='Open in PubMed'>Ramm et al., 2006</a>; <a href='http://pubmed.org/17617058' target='_blank' title='Open in PubMed'>Geraghty et al., 2007</a>).",S595,Q8BYJ6,"12637568, 19897488",3qyb32814,AS160,"Promotes 14-3-3 binding (although T649 is primary binding site). Disrupts GTPase-activating (GAP) function of AS160 and promotes translocation of GLUT4 glucose transporter to the plasma membrane, increasing glucose uptake (<a href='http://pubmed.org/12637568' target='_blank' title='Open in PubMed'>Sano et al., 2003</a>; <a href='http://pubmed.org/16880201' target='_blank' title='Open in PubMed'>Ramm et al., 2006</a>; <a href='http://pubmed.org/17617058' target='_blank' title='Open in PubMed'>Geraghty et al., 2007</a>).",T649,Q8BYJ6,"12637568, 16880201, 17617058",3qyb11092,MSK1,"The mitogen- and stress-activated kinase 1 (MSK1) is initially phosphorylated by p38 MAPK and ERK1 (<a href='http://pubmed.org/11994045' target='_blank' title='Open in PubMed'>Markou & Lazou, 2002</a>; <a href='http://pubmed.org/15568999' target='_blank' title='Open in PubMed'>McCoy et al., 2005</a>), including on residue T645 (human T581), this enables MSK1 to autophosphorylate: the C-terminal kinase domain phosphorylates itself at several sites, including the hydrophobic motif at S375 (human S376). This activates the N-terminal kinase domain, enabling MSK1 to phosphorylate its substrates (<a href='http://pubmed.org/15568999' target='_blank' title='Open in PubMed'>McCoy et al., 2005</a>). This enables the cell to respond to both growth factors and cellular stress through the same kinase (e.g., <a href='http://pubmed.org/9687510' target='_blank' title='Open in PubMed'>Deak et al., 1998</a>).",S375,Q8C050,"11994045, 15568999, 9687510",3kn510659,Hsl,"PKA phosphorylates HSL on several residues. This results in the activation of HSL, promoting lipolysis and thus mobilisation of energy stores during exercise or starvation (<a href='http://pubmed.org/9417067' target='_blank' title='Open in PubMed'>Anthonsen et al., 1998</a>; <a href='http://pubmed.org/19018281' target='_blank' title='Open in PubMed'>Krintel et al., 2008</a>).",S632,Q8CDI9,"9417067, 19018281",10665,Hsl,"AMPK phosphorylates mouse S559 (rat S565) (<a href='http://pubmed.org/2537200' target='_blank' title='Open in PubMed'>Garton et al., 1989</a>). Phosphorylation of S559 is present in the 'basal' state (in the absence of lipolytic stimuli) and has little effect on HSL activity (<a href='http://pubmed.org/2537200' target='_blank' title='Open in PubMed'>Garton et al., 1989</a>; <a href='http://pubmed.org/15033481' target='_blank' title='Open in PubMed'>Donsmark et al., 2004</a>; <a href='http://pubmed.org/15308678' target='_blank' title='Open in PubMed'>Roepstorff et al., 2004</a>). There is some evidence that it reduces phosphorylation at mouse S557 (rat S563) by PKA (<a href='http://pubmed.org/16188906' target='_blank' title='Open in PubMed'>Watt et al., 2006</a>; <a href='http://pubmed.org/2537200' target='_blank' title='Open in PubMed'>Garton et al., 1989</a>; <a href='http://pubmed.org/2165906' target='_blank' title='Open in PubMed'>Garton & Yeaman, 1990</a>), which is needed for HSL activity in mediating lipolysis (<a href='http://pubmed.org/9636039' target='_blank' title='Open in PubMed'>Shen et al., 1998</a>).",S555,Q8CDI9,2537200,9506,Plin1,"Protein kinase A phosphorylates Plin1 (perilipin A) at S492, which promotes access of lipases to lipid droplets in adipocytes, leading to lipid droplet breakdown and lipolysis (<a href='http://pubmed.org/16488886' target='_blank' title='Open in PubMed'>Marcinkiewicz et al., 2006</a>; <a href='http://pubmed.org/17114792' target='_blank' title='Open in PubMed'>Miyoshi et al., 2007</a>). This serves to mobilise energy during fasting and exercise.",S492,Q8CGN5,"16488886, 17114792",8254,Edc3,"Promotes 14-3-3 binding, which impairs its role in mRNA decay and translation repression at p-bodies (<a href='http://pubmed.org/20051463' target='_blank' title='Open in PubMed'>Larance et al., 2010</a>). This provides one avenue for insulin to increase protein synthesis.",S161,Q8K2D3,20051463,3d3j6505,Pras40,"Akt phosphorylates PRAS40 at T247 (<a href='http://pubmed.org/12524439' target='_blank' title='Open in PubMed'>Kovacina et al., 2003</a>; <a href='http://pubmed.org/17386266' target='_blank' title='Open in PubMed'>Sancak et al., 2007</a>; <a href='http://pubmed.org/17277771' target='_blank' title='Open in PubMed'>Vander et al., 2007</a>), which promotes mTORC1 to phosphorylate PRAS40 at multiple sites, including S184 (<a href='http://pubmed.org/20138985' target='_blank' title='Open in PubMed'>Nascimento et al., 2010</a>; <a href='http://pubmed.org/17517883' target='_blank' title='Open in PubMed'>Oshiro et al., 2007</a>). Together, these phosphorylation events cause PRAS40 to dissociate from mTORC1 and bind 14-3-3. Combined with Akt-mediated TSC2 phosphorylation, this results in mTORC1 activation.",S159,Q9D1F4,"12524439, 17386266, 17277771, 17517883, 20138985",32018,Pras40,"Akt phosphorylates PRAS40 at T247 (<a href='http://pubmed.org/12524439' target='_blank' title='Open in PubMed'>Kovacina et al., 2003</a>; <a href='http://pubmed.org/17386266' target='_blank' title='Open in PubMed'>Sancak et al., 2007</a>; <a href='http://pubmed.org/17277771' target='_blank' title='Open in PubMed'>Vander et al., 2007</a>), which promotes mTORC1 to phosphorylate PRAS40 at multiple sites, including S184 (<a href='http://pubmed.org/20138985' target='_blank' title='Open in PubMed'>Nascimento et al., 2010</a>; <a href='http://pubmed.org/17517883' target='_blank' title='Open in PubMed'>Oshiro et al., 2007</a>). Together, these phosphorylation events cause PRAS40 to dissociate from mTORC1 and bind 14-3-3. Combined with Akt-mediated TSC2 phosphorylation, this results in mTORC1 activation.",T270,Q9D1F4,"12524439, 17386266, 17277771, 17517883, 20138985",11843,mTOR,"Upon activation, mTOR autophosphorylates itself on S2481 (<a href='http://pubmed.org/10702316' target='_blank' title='Open in PubMed'>Peterson et al., 2000</a>), being observed in both complexes mTORC1 and mTORC2 (<a href='http://pubmed.org/20022946' target='_blank' title='Open in PubMed'>Soliman et al., 2010</a>). Although diagonistic of mTOR activity, the physiological significance of this autophosphorylation site remains elusive.",S2481,Q9JLN9,"10702316, 20022946",2gaq11851,mTOR,"Originally considered an Akt target (<a href='http://pubmed.org/10910062' target='_blank' title='Open in PubMed'>Sekulić et al., 2000</a>; <a href='http://pubmed.org/10567225' target='_blank' title='Open in PubMed'>Navé et al., 1999</a>), more recent evidence suggests that S2448 is actually phosphorylated by p70-S6K (<a href='http://pubmed.org/15899889' target='_blank' title='Open in PubMed'>Chiang & Abraham, 2005</a>; <a href='http://pubmed.org/15905173' target='_blank' title='Open in PubMed'>Holz & Blenis, 2005</a>). This presents a feedback loop, although its function has not been elucidated. Since S2448 lies within the repressor domain, it has been speculated that phosphorylation at this site represses mTOR activity (<a href='http://pubmed.org/10910062' target='_blank' title='Open in PubMed'>Sekulić et al., 2000</a>), but does not affect mTORC1 complex formation (<a href='http://pubmed.org/19145465' target='_blank' title='Open in PubMed'>Rosner et al., 2010</a>).",S2448,Q9JLN9,"10910062, 10567225, 15899889, 15905173, 19145465",2gaq32167,Ndrg2,"SGK kinases phosphorylate T330, S332, and T348 of NDRG2 - there is some evidence that this primes NDRG2 for phosphorylation by GSK3 (<a href='http://pubmed.org/15461589' target='_blank' title='Open in PubMed'>Murray et al., 2004</a>). The functional consequences of this have not been well-studied.",T330,Q9QYG0,15461589,2qmq32169,Ndrg2,"SGK kinases phosphorylate T330, S332, and T348 of NDRG2 - there is some evidence that this primes NDRG2 for phosphorylation by GSK3 (<a href='http://pubmed.org/15461589' target='_blank' title='Open in PubMed'>Murray et al., 2004</a>). The functional consequences of this have not been well-studied.",T348,Q9QYG0,15461589,2qmq4288,GSK3b,"GSK3a/b are unique kinase in that they requires its substrate to be phosphorylated at a residue +4 of the GSK3 target site. The GSK3 domain that binds this 'priming site' is occupied by the GSK3 N-terminus when S9/21 (GSK3b/a) is phosphorylated by Akt (<a href='http://pubmed.org/11430833' target='_blank' title='Open in PubMed'>Frame et al., 2001</a>). This leads to disrupted GSK3 activity (<a href='http://pubmed.org/8524413' target='_blank' title='Open in PubMed'>Cross et al., 1995</a>). This not only derepresses glycogen synthesis (<a href='http://pubmed.org/8816781' target='_blank' title='Open in PubMed'>Eldar-Finkelman et al., 1996</a>), for which GSK3 is named, but influences a wide range of cellular processes (reviewed in <a href='http://pubmed.org/11579232' target='_blank' title='Open in PubMed'>Woodgett, 2001</a>).",S9,Q9WV60,"11430833, 8524413, 8816781, 11579232",4nm04508,Foxo3a,"Promotes 14-3-3 binding and subsequent export from the nucleus. This prevents its regulation of target genes, including those involved in apoptosis (<a href='http://pubmed.org/10102273' target='_blank' title='Open in PubMed'>Brunet et al., 1999</a>; <a href='http://pubmed.org/11864996' target='_blank' title='Open in PubMed'>Brunet et al., 2002</a>).",S252,Q9WVH4,"10102273, 11864996",2uzk5572,Gys,"GSK3 phosphorylates Gys at consecutive serines (S641, S645, S649, S653) in a C->N direction (<a href='http://pubmed.org/6249596' target='_blank' title='Open in PubMed'>Embi et al., 1980</a>; <a href='http://pubmed.org/6772446' target='_blank' title='Open in PubMed'>Rylatt et al., 1980</a>). Once S641 is phosphorylated, Gys activity is reduced, now depending on glucose-6-phosphate for allosteric activation (<a href='http://pubmed.org/7759494' target='_blank' title='Open in PubMed'>Skurat & Roach, 1995</a>; <a href='http://pubmed.org/8226927' target='_blank' title='Open in PubMed'>Wang & Roach, 1993</a>). Upon insulin stimulation, GSK3 is inhibited, de-repressing Gys and thus stimulating glycogen synthesis (<a href='http://pubmed.org/14745035' target='_blank' title='Open in PubMed'>Schafer et al., 2004</a>; <a href='http://pubmed.org/22248338' target='_blank' title='Open in PubMed'>Roach et al., 2012</a>).",S641,Q9Z1E4,"6249596, 6772446, 7759494, 8226927, 14745035, 22248338",4kqm5575,Gys,"GSK3 phosphorylates Gys at consecutive serines (S641, S645, S649, S653) in a C->N direction (<a href='http://pubmed.org/6249596' target='_blank' title='Open in PubMed'>Embi et al., 1980</a>; <a href='http://pubmed.org/6772446' target='_blank' title='Open in PubMed'>Rylatt et al., 1980</a>). Once S641 is phosphorylated, Gys activity is reduced, now depending on glucose-6-phosphate for allosteric activation (<a href='http://pubmed.org/7759494' target='_blank' title='Open in PubMed'>Skurat & Roach, 1995</a>; <a href='http://pubmed.org/8226927' target='_blank' title='Open in PubMed'>Wang & Roach, 1993</a>). Upon insulin stimulation, GSK3 is inhibited, de-repressing Gys and thus stimulating glycogen synthesis (<a href='http://pubmed.org/14745035' target='_blank' title='Open in PubMed'>Schafer et al., 2004</a>; <a href='http://pubmed.org/22248338' target='_blank' title='Open in PubMed'>Roach et al., 2012</a>).",S649,Q9Z1E4,"6249596, 6772446, 7759494, 8226927, 14745035, 22248338",4kqm